Dead-end pages
The following pages do not link to other pages in greek.doctor.
Showing below up to 50 results in range #151 to #200.
- 15. Nodular calcified aortic stenosis
- 15. Normal and hypertrophic cardiac muscle
- 15. Pathomechanism and clinicopathological forms of stone formation
- 15. Sensation
- 15. Toxoplasma lymphadenitis
- 15. Tumours and tumourlike conditions of the liver
- 15A. Trigeminal neuralgia
- 15B. Neuromyelitis optica (Devic-disease)
- 16. Agents acting on the biosynthesis, storage, release and elimination of catecholamines
- 16. Cerebral atrophy
- 16. Cholelithiasis (aetiology and complications) and pathology of the extrahepatic biliary tract
- 16. Cirrhosis. Causes, mechanisms and consequences. Hepatic cachexia.
- 16. Epidemiological indicators I: indicators of disease frequency and population impact of a disease
- 16. Epidemiology and prevention of prostate and cervix cancer
- 16. Follicular lymphoma
- 16. General characterisation of amyloidosis. Physico-chemical, ultrastructural and histochemical nature of amyloid. Types of amyloid
- 16. Interaction of environmental and genetical factors in disease development
- 16. Nervous system I
- 16. Neurulation. The structure of the neural tube. Development of the spinal cord
- 16. Organ manifestations of shock
- 16. Origin and function of blood platelets
- 16. Prostatic hyperplasia
- 16. Synthesis of biologically active molecules from amino acids
- 16. T-helper cell mediated macrophage activation, delayed type hypersensitivity
- 16A. Clinical symptoms of insufficient blood supply in territory of carotid and vertebral artery (+ the anterior circulation)
- 16B. Differential diagnosis of short-term loss of consciousness
- 17. Acute and chronic pancreatitis. Tumours of the pancreas
- 17. Adenocarcinoma of the gall bladder with multiple liver metastases
- 17. Adrenergic receptor agonists
- 17. Benign and malignant tumours of the paranasal sinuses
- 17. CLL or SLL infiltration in lymph node
- 17. Concentric hypertrophy of the left ventricle of the heart
- 17. Development of the brainstem and the cerebellum
- 17. Epidemiological indicators II: definition and measures of relative risk and odds ratio
- 17. Epidemiology and prevention of liver-, pancreas- and gastric cancer
- 17. Genomics and epigenetics in public health. Nutrigenomics
- 17. Glandular cystic hyperplasia of the endometrium
- 17. Immunological memory, primary and secondary immune response
- 17. Nervous system II
- 17. Nucleotide synthesis and degradation
- 17. Pathology of obesity and diabetes
- 17. Portal hypertension
- 17. The basic structure and metabolism of haemoglobin and the metabolism of iron
- 17. Tissue hypoxia, ischemia, reperfusion and tissue metabolism
- 17A. Types and etiology of unconsciousness. Coma
- 17B. Status epilepticus
- 18. Adrenergic receptor antagonists (alpha blockers and beta blockers)
- 18. Ascites and hepatorenal syndrome
- 18. Causes of atrophy; general gross morphology and microscopical characteristics. Pathomechanism of atrophy. Hypoplasia, aplasia, agenesia. Osteoporosis.
- 18. Development of the diencephalon and the telencephalon. Development of the commissural pathways and the fornix